Positive topline results from phase 2 recurrent ovarian cancer trial
Rare oral cancer has distinct genetic profile
New tool decodes structures and motifs of RNA
Elite immune cells lead fight against multiple myeloma
Pfizer metastatic colorectal cancer treatment gets FDA approval
Every Cure to receive up to $76m to advance AI-identified drug repurposing opportunities
Key protein in Alzheimer’s disease protection
Machine-learning biomarker identifies those at high risk for liver cancer
New AI approach enables diagnosis and monitoring of brain tumours
Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Korsana Biosciences emerges from stealth with $175m to tackle neurodegenerative diseases
New centre for cell research